Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients

被引:34
作者
Goei, Dustin [2 ]
Hoeks, Sanne E. [3 ]
Boersma, Eric [3 ]
Winkel, Tamara A. [2 ]
Dunkelgrun, Martin [2 ]
Flu, Willem-Jan [3 ]
Schouten, Olaf [2 ]
Bax, Jeroen J. [1 ]
Poldermans, Don [1 ,4 ]
机构
[1] Erasmus MC, Dept Anesthesiol, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Vasc Surg, NL-3015 GD Rotterdam, Netherlands
[3] Erasmus MC, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands
[4] Leiden Med Ctr, Dept Cardiol, Leiden, Netherlands
关键词
cardiovascular risk prediction; high-sensitivity C-reactive protein; noncardiac vascular surgery; N-terminal pro-B-type natriuretic peptide; CORONARY-ARTERY-DISEASE; PROGNOSTIC VALUE; RISK; MORTALITY; MARKER;
D O I
10.1097/MCA.0b013e3283219e47
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives High-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with the presence of coronary artery disease. The aim of this study was to assess the prognostic value of hs-CRP and NT-proBNP for postoperative cardiac events in noncardiac vascular surgery patients. Methods In 592 patients, cardiac history, hs-CRP, and NT-proBNP levels were assessed preoperatively. Levels of hs-CRP of at least 6.5 mg/l and NT-proBNP of at least 350 pg/ml were defined as the optimal cut-off values for the prediction of postoperative cardiac events. The end point was the composite of 30-day cardiovascular death, Q-wave myocardial infarction, and troponin T release. Multivariable regression analysis was used to evaluate the association between hs-CRP, NT-proBNP and the end point. The performance of the risk models based on cardiac risk factors alone and the addition of both biomarkers was determined using C statistics. Results After adjustment for cardiac risk factors, site of surgery and type of procedure, elevated levels of hs-CRP (odds ratio 2.54; 95% confidence interval 1.50-4.30) and NT-proBNP (odds ratio 4.78; 95% confidence interval 2.71-8.42) remained independent predictors for postoperative cardiac events. When hs-CRP and NT-proBNP were added to the cardiac risk score, the C statistic improved from 0.79 to 0.84. A combined elevation of hs-CRP and NT-proBNP provided a seven-fold higher risk for postoperative cardiac events. Conclusion Both hs-CRP and NT-proBNP have additional value in the prediction of postoperative cardiac events in vascular surgery patients. Their integrated use improves cardiac risk stratification. Coron Artery Dis 20:219-224 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 25 条
[1]   Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients [J].
Dernellis, J. ;
Panaretou, M. .
HEART, 2006, 92 (11) :1645-1650
[2]   RETRACTED: Baseline plasma N-terminal pro-B-type natriuretic peptide is associated with the extent of stress-induced myocardial ischernia during dobutamine stress echocardiography (Retracted Article) [J].
Feringa, Harm H. H. ;
Elhendy, Abdou ;
Bax, Jeroen J. ;
Boersma, Eric ;
de Jonge, Robert ;
Schouten, Olaf ;
Karagiannis, Stefanos E. ;
Schinkel, Arend F. L. ;
Lindemans, Jan ;
Poldermans, Don .
CORONARY ARTERY DISEASE, 2006, 17 (03) :255-259
[3]   Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function [J].
Froissart, M ;
Rossert, J ;
Jacquot, C ;
Paillard, M ;
Houillier, P .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03) :763-773
[4]   Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery [J].
Goei, Dustin ;
Schouten, Olaf ;
Boersma, Eric ;
Welten, Gijs M. J. M. ;
Dunkelgrun, Martin ;
Lindemans, Jan ;
van Gestel, Yvette R. B. M. ;
Hoeks, Sanne E. ;
Bax, Jeroen J. ;
Poldermans, Don .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (01) :122-126
[5]   RAPID VENTRICULAR INDUCTION OF BRAIN NATRIURETIC PEPTIDE GENE-EXPRESSION IN EXPERIMENTAL ACUTE MYOCARDIAL-INFARCTION [J].
HAMA, N ;
ITOH, H ;
SHIRAKAMI, G ;
NAKAGAWA, O ;
SUGA, S ;
OGAWA, Y ;
MASUDA, I ;
NAKANISHI, K ;
YOSHIMASA, T ;
HASHIMOTO, Y ;
YAMAGUCHI, M ;
HORI, R ;
YASUE, H ;
NAKAO, K .
CIRCULATION, 1995, 92 (06) :1558-1564
[6]  
Hammerer-Lercher A, 2001, Clin Lab, V47, P265
[7]  
Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
[8]   RENAL, ENDOCRINE, AND HEMODYNAMIC-EFFECTS OF HUMAN BRAIN NATRIURETIC PEPTIDE IN NORMAL MAN [J].
HOLMES, SJ ;
ESPINER, EA ;
RICHARDS, AM ;
YANDLE, TG ;
FRAMPTON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :91-96
[9]   N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease -: A Global Utilization of Strategies to Open occluded arteries (GUSTO)-IV substudy [J].
James, SK ;
Lindahl, B ;
Siegbahn, A ;
Stridsberg, M ;
Venge, P ;
Armstrong, P ;
Barnathan, ES ;
Califf, R ;
Topol, EJ ;
Simoons, ML ;
Wallentin, L .
CIRCULATION, 2003, 108 (03) :275-281
[10]   Routine measurement of radioisotope left ventricular ejection fraction prior to vascular surgery: Is it worthwhile? [J].
Karkos, CD ;
Baguneid, MS ;
Triposkiadis, F ;
Athanasiou, E ;
Spirou, P .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2004, 27 (03) :227-238